Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

DKK 2016 | Precision medicine for lymphoma: Defining the individual patient

Lorenz Trümper • 25 Feb 2016
DKK 2016
Hodgkin Lymphoma Non-Hodgkin Lymphoma

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Lorenz Trümper, MD, from University Hospital of Göttingen, Göttingen, Germany, reviews the development of more tailored approaches for the treatment of lymphoma that have improved outcomes in patients.

More from Lorenz Trümper

Treatment of lymphoma: Overview of the continued progress
5:02
Treatment of lymphoma: Overview of the continued progress
Lorenz Trümper • 25 Feb 2016

Related Videos

Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
2:39
Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
Tina Bagratuni • 23 Sep 2026
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
2:13
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
Mary Jo Lechowicz • 11 Sep 2026
Key advances in FL management expected to change practice over the next five years
1:26
Key advances in FL management expected to change practice over the next five years
Kim Linton • 11 Sep 2026
Community lymphoma management: which patients should be prioritized for specialist referral?
1:16
Community lymphoma management: which patients should be prioritized for specialist referral?
Nirav Niranjan Shah • 10 Sep 2026
The content of VJHemOnc is intended for healthcare professionals